Vitaliy Khutoryanskiy

From WikiMD's Medical Encyclopedia

Revision as of 02:12, 18 March 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Vitaliy Khutoryanskiy is a renowned pharmaceutical scientist and academic, known for his significant contributions to the field of pharmaceutical sciences. He is currently a Professor of Pharmaceutics at the University of Reading, where he leads a research group focused on the development of advanced drug delivery systems and biomaterials.

Early Life and Education[edit]

Vitaliy Khutoryanskiy was born and raised in Ukraine. He completed his undergraduate studies in Chemistry at the Taras Shevchenko National University of Kyiv. He then pursued his PhD in Polymer Chemistry from the same university.

Career[edit]

After completing his PhD, Khutoryanskiy moved to the United Kingdom where he joined the University of Reading as a Postdoctoral Researcher. He later became a Lecturer in the School of Pharmacy, and was subsequently promoted to Professor of Pharmaceutics.

His research interests include the development of mucoadhesive materials, hydrogels, and nanoparticles for drug delivery. He has published numerous peer-reviewed articles in these areas and has received several awards for his work.

Research Contributions[edit]

Khutoryanskiy's research has significantly advanced the field of drug delivery. His work on mucoadhesive materials has led to the development of new strategies for delivering drugs to mucosal surfaces. His research on hydrogels has contributed to the understanding of their properties and potential applications in drug delivery. He has also made significant contributions to the field of nanoparticle drug delivery, developing new methods for the preparation and characterization of nanoparticles.

Awards and Honors[edit]

Over the course of his career, Khutoryanskiy has received several awards and honors for his contributions to the field of pharmaceutical sciences. These include the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Research Starter Grant and the American Association of Pharmaceutical Scientists (AAPS) New Investigator Grant in Pharmaceutics and Drug Delivery.

See Also[edit]

References[edit]

<references />

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.